Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Other Non-Current Assets (2020 - 2026)

Aura Biosciences filings provide 7 years of Other Non-Current Assets readings, the most recent being $517000.0 for Q1 2026.

  • Quarterly Other Non-Current Assets fell 32.68% to $517000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $517000.0 through Mar 2026, down 32.68% year-over-year, with the annual reading at $471000.0 for FY2025, 9.07% down from the prior year.
  • Other Non-Current Assets hit $517000.0 in Q1 2026 for Aura Biosciences, up from $471000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $893000.0 in Q2 2022 and bottomed at $125000.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $612176.5, with a median of $768000.0 recorded in 2022.
  • The largest annual shift saw Other Non-Current Assets soared 614.4% in 2022 before it tumbled 75.91% in 2025.
  • Aura Biosciences' Other Non-Current Assets stood at $768000.0 in 2022, then tumbled by 33.72% to $509000.0 in 2023, then rose by 1.77% to $518000.0 in 2024, then fell by 9.07% to $471000.0 in 2025, then rose by 9.77% to $517000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Other Non-Current Assets are $517000.0 (Q1 2026), $471000.0 (Q4 2025), and $277000.0 (Q3 2025).